From Casetext: Smarter Legal Research

Alpha Capital Anstalt v. Gen. Biotechnology

Appellate Division of the Supreme Court of the State of New York
Feb 16, 2021
191 A.D.3d 515 (N.Y. App. Div. 2021)

Opinion

13123 Index No. 650918/19 Case No. 2020-03540

02-16-2021

ALPHA CAPITAL ANSTALT, Plaintiff–Respondent, v. GENERAL BIOTECHNOLOGY CORPORATION. et al., Defendants–Appellants.

Barket Epstein Kearon Aldea & Loturco, LLP, Garden City (Alexander R. Klein of counsel), for appellants. Hoffner PLLC, New York (David S. Hoffner of counsel), for respondent.


Barket Epstein Kearon Aldea & Loturco, LLP, Garden City (Alexander R. Klein of counsel), for appellants.

Hoffner PLLC, New York (David S. Hoffner of counsel), for respondent.

Gische, J.P., Moulton, Gonza´lez, Scarpulla, JJ.

Order, Supreme Court, New York County (Barry R. Ostrager, J.), entered on or about May 28, 2020, which granted plaintiff's motion to strike defendant's eleventh affirmative defense alleging violation of public policy, unanimously affirmed, with costs.

When moving to dismiss an affirmative defense pursuant to CPLR 3211(b), "the plaintiff bears the heavy burden of showing that the defense is without merit as a matter of law" ( Granite State Ins. Co. v. Transatlantic Reins. Co., 132 A.D.3d 479, 481, 19 N.Y.S.3d 13 [1st Dept. 2015] ). The allegations in the answer must be viewed in the light most favorable to the defendant ( id. ), and "the defendant is entitled to the benefit of every reasonable intendment of the pleading, which is to be liberally construed" ( 534 E. 11th St. Hous. Dev. Fund Corp. v. Hendrick, 90 A.D.3d 541, 542, 935 N.Y.S.2d 23 [1st Dept. 2011] ).

Defendants' eleventh affirmative defense, claiming that the note and contracts at issue in this case are void as against public policy, rests entirely on the fact that plaintiff was charged with violations of federal securities laws in an action brought by the Securities and Exchange Commission. That action charged plaintiff with a violation of federal securities law in connection with market manipulation or pump-and-dump schemes by other individuals and entities involving the stock of three other companies. Although plaintiff acknowledged wrongdoing in its settlement of the SEC action and paid a substantial fine, defendants fail to articulate a nexus between the conduct at issue in the SEC action and the note and guaranty at issue in this action. At most, defendants speculated in their opposition to the motion that plaintiff engaged in a similar pump-and-dump scheme involving their stock, noting highly unusual trading during a particular time period. Even viewing the pleadings, supplemented by defendants' submissions, in the light most favorable to defendants, defendants did not plead a public policy defense based on violation of federal securities laws with any specificity (see CPLR 3013, 3016 ).


Summaries of

Alpha Capital Anstalt v. Gen. Biotechnology

Appellate Division of the Supreme Court of the State of New York
Feb 16, 2021
191 A.D.3d 515 (N.Y. App. Div. 2021)
Case details for

Alpha Capital Anstalt v. Gen. Biotechnology

Case Details

Full title:Alpha Capital Anstalt, Plaintiff-Respondent, v. General Biotechnology…

Court:Appellate Division of the Supreme Court of the State of New York

Date published: Feb 16, 2021

Citations

191 A.D.3d 515 (N.Y. App. Div. 2021)
191 A.D.3d 515
2021 N.Y. Slip Op. 985

Citing Cases

E.E. Cruz & Co. v. Starr Surplus Lines Ins. Co.

"A party may move for judgment dismissing one or more defenses, on the ground that a defense is not stated…

Williams v. McAine Contracting Co.

The movant bears the burden of establishing the defense or counterclaim is without merit as a matter of law…